Functional phosphoproteomic analysis reveals cold-shock domain protein a to be a Bcr-Abl effector-regulating proliferation and transformation in chronic myeloid leukemia

Cell Death and Disease

Volumn 1, Issue 11, 2010, Pages

  Sears, D ^a,b   Luong, P ^a   Yuan, M ^a   Nteliopoulos, G ^b   Man, Y K S ^a   Melo, J V ^b,c   Basu, S ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CENTRE FOR CANCER BIOLOGY   (Australia)

Author keywords

Bcr Abl; CML; CSDA; Mass spectrometry; Phosphorylation; Proliferation; Proteomics

Indexed keywords

BCR ABL PROTEIN; COLD SHOCK DOMAIN PROTEIN A; COLD SHOCK PROTEIN; IMATINIB; PROTEIN KINASE B; PROTEIN P90; S6 KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CCAAT ENHANCER BINDING PROTEIN; CSDA PROTEIN, HUMAN; HEAT SHOCK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHOPEPTIDE; PIPERAZINE DERIVATIVE; PROTEIN 14 3 3; PROTEOME; PYRIMIDINE DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; EPITHELIUM CELL; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

14-3-3 PROTEINS; ANTINEOPLASTIC AGENTS; CCAAT-ENHANCER-BINDING PROTEINS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FUSION PROTEINS, BCR-ABL; HEAT-SHOCK PROTEINS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MASS SPECTROMETRY; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PHOSPHOPEPTIDES; PHOSPHORYLATION; PIPERAZINES; PROTEOME; PROTO-ONCOGENE PROTEINS C-AKT; PYRIMIDINES; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 79958736832     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2010.72     Document Type: Article

References (48)

1. Melo JV, Barnes DJ. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 2007; 7: 441-453. (Pubitemid 46823444)
2. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 1987; 328: 342-344. (Pubitemid 17097654)
3. Verfaillie CM, Hurley R, Lundell BI, Zhao C, Bhatia R. Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors? Acta Haematol 1997; 97: 40-52. (Pubitemid 26413947)
4. Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ. Inhibition of apoptosis by BCRABL in chronic myeloid leukemia. Blood 1994; 83: 2038-2044. (Pubitemid 24112713)
5. Goldman JM, Melo JV. BCR-ABL in chronic myelogenous leukemia-how does it work? Acta Haematol 2008; 119: 212-217.
6. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001; 344: 1038-1042. (Pubitemid 32267973)
7. Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG et al. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood 2002; 99: 3530-3539. (Pubitemid 34534519)
8. Basu S, Totty NF, Irwin MS, Sudol M, Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 2003; 11: 11-23. (Pubitemid 36126587)
9. Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK et al. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Aktdependent pathway. EMBO J 1997; 16: 6151-6161. (Pubitemid 27458335)
10. Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G et al. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood 1995; 86: 726-736.
11. Morrison DK. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 2009; 19: 16-23.
12. Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 2003; 3: 931-943. (Pubitemid 37500178)
13. Sano H, Liu SC, Lane WS, Piletz JE, Lienhard GE. Insulin receptor substrate 4 associates with the protein IRAS. J Biol Chem 2002; 277: 19439-19447. (Pubitemid 34967453)
14. Aitken A, Baxter H, Dubois T, Clokie S, Mackie S, Mitchell K et al. Specificity of 14-3-3 isoform dimer interactions and phosphorylation. Biochem Soc Trans 2002; 30: 351-360. (Pubitemid 35001556)
15. Benzinger A, Muster N, Koch HB, Yates III JR, Hermeking H. Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Mol Cell Proteomics 2005; 4: 785-795. (Pubitemid 40873007)
16. Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S et al. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 2007; 3: 89.
17. Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, Kulkarni S et al. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 2004; 14: 1436-1450. (Pubitemid 39123741)
18. Nellist M, Goedbloed MA, de Winter C, Verhaaf B, Jankie A, Reuser AJ et al. Identification and characterization of the interaction between tuberin and 14-3-3zeta. J Biol Chem 2002; 277: 39417-39424. (Pubitemid 35190916)
19. Pozuelo Rubio M, Peggie M, Wong BH, Morrice N, MacKintosh C. 14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6- bisphosphate kinase/phosphatase. EMBO J 2003; 22: 3514-3523. (Pubitemid 36898329)
20. Trinczek B, Brajenovic M, Ebneth A, Drewes G. MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes. J Biol Chem 2004; 279: 5915-5923. (Pubitemid 38220624)
21. Tzivion G, Luo ZJ, Avruch J. Calyculin A-induced vimentin phosphorylation sequesters 14-3-3 and displaces other 14-3-3 partners in vivo. J Biol Chem 2000; 275: 29772-29778. (Pubitemid 32043861)
22. Yoshida K, Yamaguchi T, Natsume T, Kufe D, Miki Y. JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat Cell Biol 2005; 7: 278-285. (Pubitemid 40331129)
23. Pozuelo Rubio M, Geraghty KM, Wong BH, Wood NT, Campbell DG, Morrice N et al. 14-3- 3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem J 2004; 379 (Part 2): 395-408. (Pubitemid 38570113)
24. Sourisseau T, Georgiadis A, Tsapara A, Ali RR, Pestell R, Matter K et al. Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA. Mol Cell Biol 2006; 26: 2387-2398. (Pubitemid 43346937)
25. Balda MS, Garrett MD, Matter K. The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol 2003; 160: 423-432. (Pubitemid 36182732)
26. Wang GR, Zheng Y, Che XM, Wang XY, Zhao JH, Wu KJ et al. Upregulation of human DNA binding protein A (dbpA) in gastric cancer cells. Acta Pharmacol Sin 2009; 30: 1436-1442.
27. Crawford NP, Yang H, Mattaini KR, Hunter KW. The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor. J Biol Chem 2009; 284: 28660-28673.
28. Sutherland BW, Kucab J, Wu J, Lee C, Cheang MC, Yorida E et al. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 2005; 24: 4281-4292. (Pubitemid 40961781)
29. Feller SM. Crk family adaptors-signalling complex formation and biological roles. Oncogene 2001; 20: 6348-6371. (Pubitemid 32977844)
30. Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E et al. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-30 kinase pathway. Oncogene 1996; 12: 839-846.
31. Roux PP, Richards SA, Blenis J. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol Cell Biol 2003; 23: 4796-4804. (Pubitemid 36793327)
32. Richards SA, Dreisbach VC, Murphy LO, Blenis J. Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1. Mol Cell Biol 2001; 21: 7470-7480. (Pubitemid 32953497)
33. Kin Y, Li G, Shibuya M, Maru Y. The Dbl homology domain of BCR is not a simple spacer in P210BCR-ABL of the Philadelphia chromosome. J Biol Chem 2001; 276: 39462-39468.
34. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993; 75: 175-185. (Pubitemid 23306031)
35. Anjum R, Blenis J. The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 2008; 9: 747-758.
36. Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS, Taunton J et al. RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates capdependent translation. J Biol Chem 2007; 282: 14056-14064. (Pubitemid 47100467)
37. Lima WR, Parreira KS, Devuyst O, Caplanusi A, N0Kuli F, Marien B et al. ZONAB promotes proliferation and represses differentiation of proximal tubule epithelial cells. J Am Soc Nephrol 2010; 21: 478-488.
38. Bader AG, Vogt PK. Phosphorylation by Akt disables the anti-oncogenic activity of YB-1. Oncogene 2008; 27: 1179-1182. (Pubitemid 351253182)
39. Evdokimova V, Ruzanov P, Anglesio MS, Sorokin AV, Ovchinnikov LP, Buckley J et al. Aktmediated YB-1 phosphorylation activates translation of silent mRNA species. Mol Cell Biol 2006; 26: 277-292.
40. Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, Fink D et al. Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 2009; 15: 402-415.
41. Ma Z, Cools J, Marynen P, Cui X, Siebert R, Gesk S et al. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. Blood 2000; 95: 2144-2149. (Pubitemid 30151658)
42. Kanno H, Fujii H, Hirono A, Ishida Y, Ohga S, Fukumoto Y et al. Molecular analysis of glucose phosphate isomerase deficiency associated with hereditary hemolytic anemia. Blood 1996; 88: 2321-2325. (Pubitemid 26307937)
43. Scatena R, Bottoni P, Pontoglio A, Mastrototaro L, Giardina B. Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Invest Drugs 2008; 17: 1533-1545.
44. Sheng H, Niu B, Sun H. Metabolic targeting of cancers: from molecular mechanisms to therapeutic strategies. Curr Med Chem 2009; 16: 1561-1587.
45. Yoshida C, Yoshida F, Sears DE, Hart SM, Ikebe D, Muto A et al. Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1. Blood 2007; 109: 1211-1219. (Pubitemid 46220670)
46. Griswold IJ, MacPartlin M, Bumm T, Goss VL, O'Hare T, Lee KA et al. Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib. Mol Cell Biol 2006; 26: 6082-6093. (Pubitemid 44204527)
47. Naviaux RK, Costanzi E, Haas M, Verma IM. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 1996; 70: 5701-5705. (Pubitemid 26240755)
48. Tomlinson V, Gudmundsdottir K, Luong P, Leung KY, Knebel A, Basu S. JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis 2010; 1: e29.